C-Reactive Protein and Risk of Venous Thromboembolism in the General Population

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.109.198473
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Hematocrit and Risk of Venous Thromboembolism in a General Population. The Tromso Study

Haematologica
Hematology
2009English

Venous Thromboembolism Prevention in Emergency General Surgery

JAMA Surgery
Surgery
2018English

Secondary Polycythemia and the Risk of Venous Thromboembolism

Journal of Clinical Medicine Research
2014English

Venous Thromboembolism an Observational Study to Assess the Risk of Venous Thromboembolism in Surgical Patients.

The Professional Medical Journal
2019English

C-Reactive Protein and Risk of Lung Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

P2-346 the Risk of Venous Thromboembolism in and Around Pregnancy: A Population-Based Cohort Study

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2011English

Hospitalisation for Venous Thromboembolism in Cancer Patients and the General Population: A Population-Based Cohort Study in Denmark, 1997–2006

British Journal of Cancer
Cancer ResearchOncology
2010English

The Risk of Recurrent Venous Thromboembolism in Heterozygous Carriers of Factor v Leiden and a First Spontaneous Venous Thromboembolism

Archives of Internal Medicine
2002English

Identifying Risk Factors for Venous Thromboembolism

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy